T

Telix Pharmaceuticals

Develops targeted radiation diagnostics and therapies

Manager – Regulatory Affairs - Clinical Labeling

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeCanada

About the Job

Requirements

  • A bachelor's degree in life sciences is required.
  • At least five years of experience in pharmaceutical regulatory affairs, global labeling, clinical work, or clinical operations, including at least two years of experience in Investigational Medicinal Product (IMP) labeling (Clinical Labeling).
  • Experience supporting IMP clinical labeling for clinical trials across multiple regions and regulatory jurisdictions.
  • Knowledge of IMP lifecycle management.
  • In-depth understanding of relevant international, national, and regional regulatory or clinical frameworks, processes, and requirements.
  • Strong understanding of Good Manufacturing Practices (GMP), Good Clinical Practice (GCP), EU Clinical Trial Regulation (CTR), Annex VI, Annex 13, and FDA IMP requirements.
  • Proficiency with Microsoft Office applications and labeling management systems.

Responsibilities

  • Lead the creation, revision, review, agreement, and maintenance of IMP labeling and Calibration Labeling for investigational products.
  • Collaborate with internal stakeholders and external partners, including contract research organizations, contract manufacturing organizations, translation vendors, artwork vendors, and packaging vendors, to gather input and review and approve IMP labeling.
  • Ensure label content accurately reflects approved protocol requirements, product characteristics, storage conditions, and country-specific requirements.
  • Ensure regulatory compliance with local and regional laws, regulations, and internal policies governing IMP labeling, including requirements in the United States, European Union, United Kingdom, Australia, Canada, Asia-Pacific, and other participating countries. This includes EU CTR and Annex VI, EU GMP Annex 13, U.S. FDA requirements, ICH GCP guidelines, and country-specific IMP labeling requirements.
  • Provide labeling expertise during protocol development, clinical study start-up, amendments, and country expansion activities.
  • Coordinate translation activities and verification of multilingual labeling content.
  • Coordinate review and approval of IMP labeling artwork in the compliance system.
  • Manage version control and change management for IMP documentation in accordance with regulatory expectations.
  • Support submission of IMP labeling where submission or notification is required.
  • Evaluate new regulatory requirements and industry trends affecting IMP labeling, and assess their impact on existing and future studies.
  • Support regulatory inspections and audits by providing IMP documentation and subject matter expertise.
  • Serve as the regulatory point of contact for IMP labeling for assigned products, resolve issues independently, and escalate complex matters as appropriate.
  • Contribute to efficient IMP labeling processes through standardized templates, checklists, and workflows.
  • Identify process improvements, best practices, and tools to enhance IMP labeling efficiency and quality.
  • Assist with other clinical or commercial labeling activities and special projects assigned by management to support departmental objectives, business priorities, and continuous improvement initiatives.

Desired Qualifications

  • Working knowledge of Veeva is desired.

About the Company

Telix Pharmaceuticals

Develops targeted radiation diagnostics and therapies

Telix Pharmaceuticals develops and commercializes diagnostic and therapeutic products that use targeted radiation to diagnose and treat cancer and rare diseases. Its pipeline covers urologic oncology (prostate and kidney cancers), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. The treatments work by delivering targeted radiation to diseased tissues, enabling more precise decisions for treatment and allowing for personalized therapy. The company differentiates itself through a global, robust supply chain and a focus on integrating diagnostic and therapeutic options to address unmet medical needs, along with strong commitments to patient care, ethical practices, and environmental responsibility. Telix’s goal is to improve quality of life and outcomes for patients by providing targeted, clinically meaningful diagnostic and therapeutic solutions that support better treatment decisions and personalized care.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Melbourne VIC, Australia
Founded
2015

Recently Posted Jobs

Explore more opportunities at Telix Pharmaceuticals

See more jobs